Page 112 - Read Online

Mohammadi et al. J Transl Genet Genom 2020;4:238-50 I https://doi.org/10.20517/jtgg.2020.29 Page 249

35. Maeda H, Chiyonobu T, Yoshida M, Yamashita S, Zuiki M, et al. Establishment of isogenic iPSCs from an individual with SCN1A
mutation mosaicism as a model for investigating neurocognitive impairment in dravet syndrome. J Hum Genet 2016;61:565-9.
36. Fan J, Thalody G, Kwagh J, Burnett E, Shi H, et al. Assessing seizure liability using multi-electrode arrays (MEA). Toxicol In Vitro
2019;55:93-100.
37. Liu J, Sternberg AR, Ghiasvand S, Berdichevsky Y. Epilepsy-on-a-chip system for antiepileptic drug discovery. IEEE Trans Biomed Eng
2019;66:1231-41.
38. Odawara A, Matsuda N, Ishibashi Y, Yokoi R, Suzuki I. Toxicological evaluation of convulsant and anticonvulsant drugs in human
induced pluripotent stem cell-derived cortical neuronal networks using an MEA system. Sci Rep 2018;8:10416.
39. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell
2006;126:663-76.
40. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. Induction of pluripotent stem cells from adult human fibroblasts by
defined factors. Cell 2007;131:861-72.
41. Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, et al. Generation of induced pluripotent stem cells from human cord blood.
Cell Stem Cell 2009;5: 434-41.
42. Luo S, Gu X, Ma F, Liu C, Shen Y, et al. ZYZ451 protects cardiomyocytes from hypoxia-induced apoptosis via enhancing MnSOD and
STAT3 interaction. Free Radic Biol Med 2016;92:1-14.
43. Malik N, Rao MS. A review of the methods for human iPSC derivation. Methods Mol Biol 2013;997:23-33.
44. Vlahos K, Sourris K, Mayberry R, McDonald P, Bruveris FF, et al. Generation of iPSC lines from peripheral blood mononuclear cells
from 5 healthy adults. Stem Cell Res 2019;34:101380.
45. Kamath A, Ternes S, McGowan S, Moy AB. Virus-free and oncogene-free induced pluripotent stem cell reprogramming in cord blood
and peripheral blood in patients with lung disease. Regen Med 2018;13:889-915.
46. Haase A, Gohring G, Martin U. Generation of non-transgenic iPS cells from human cord blood CD34(+) cells under animal component-
free conditions. Stem Cell Res 2017;21:71-3.
47. Okumura T, Horie Y, Lai CY, Lin HT, Shoda H, et al. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral
blood-derived CD34+ cells using the auto-erasable Sendai virus vector. Stem Cell Res Ther 2019;10:185.
48. Simara P, Tesarova L, Rehakova D, Farkas S, Salingova B, et al. Reprogramming of adult peripheral blood cells into human induced
pluripotent stem cells as a safe and accessible source of endothelial cells. Stem Cells Dev 2018;27:10-22.
49. Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, et al. Reprogramming of human peripheral blood cells to induced pluripotent stem
cells. Cell Stem Cell 2010;7:20-4.
50. Merling RK, Sweeney CL, Choi U, Ravin SSD, Myers TG, et al. Transgene-free iPSCs generated from small volume peripheral blood
nonmobilized CD34+ cells. Blood 2013;121:e98-107.
51. Bang JS, Choi NY, Lee M, Ko K, Lee HJ, et al. Optimization of episomal reprogramming for generation of human induced pluripotent
stem cells from fibroblasts. Anim Cells Syst (Seoul) 2018;22:132-9.
52. Lim SJ, Ho SC, Mok PL, Tan KL, Ong AHK, et al. Induced pluripotent stem cells from human hair follicle keratinocytes as a potential
source for in vitro hair follicle cloning. Peer J 2016;4:e2695.
53. Matsumura W, Fujita Y, Nakayama C, Shinkuma S, Suzuki S, et al. Establishment of integration-free induced pluripotent stem cells from
human recessive dystrophic epidermolysis bullosa keratinocytes. J Dermatol Sci 2018;89:263-71.
54. Kimura H, Ouchi T, Shibata S, Amemiya T, Nagoshi N, et al. Stem cells purified from human induced pluripotent stem cell-derived neural
crest-like cells promote peripheral nerve regeneration. Sci Rep 2018;8:10071.
55. Shi L, Cui Y, Luan J, Zhou X, Han J. Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases.
Intractable Rare Dis Res 2016;5:192-201.
56. Gaignerie A, Lefort N, Rousselle M, Forest-Choquet V, Flippe L, et al. Urine-derived cells provide a readily accessible cell type for
feeder-free mRNA reprogramming. Sci Rep 2018;8:14363.
57. Li Y, Nguyen HV, Tsang SH. Skin biopsy and patient-specific stem cell lines. Methods Mol Biol 2016;1353:77-88.
58. Klein T, Günther K, Kwok CK, Edenhofer F, Üçeyler N. Generation of the human induced pluripotent stem cell line (UKWNLi001-A)
from skin fibroblasts of a woman with fabry disease carrying the X-chromosomal heterozygous c.708G>C (W236C) missense mutation
in exon 5 of the alpha-galactosidase-A gene. Stem Cell Res 2018;31:222-6.
59. Karumbayaram S, Lee P, Azghadi SF, Cooper AR, Patterson M, et al. From skin biopsy to neurons through a pluripotent intermediate
under good manufacturing practice protocols. Stem Cells Transl Med 2012;1:36-43.
60. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial
immunity. Science 2012;337:816-21.
61. Doudna JA, Charpentier E, Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014;346:1258096.
62. Zhang Y, Pak CH, Han Y, Ahlenius H, Zhang Z, et al. Rapid single-step induction of functional neurons from human pluripotent stem
cells. Neuron 2013;78:785-98.
63. Lee S, Lim W, Ryu HW, Jo D, Min JJ, et al. ZW800-1 for assessment of blood-brain barrier disruption in a photothrombotic stroke model.
Int J Med Sci 2017;14:1430-5.
64. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, et al. Highly efficient neural conversion of human ES and iPS
cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009;27:275-80.
65. Watabe T, Miyazono K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res 2009;19:103-15.
66. Nadadhur AG, Melero JE, Meijer M, Schut D, Jacobs G, et al. Multi-level characterization of balanced inhibitory-excitatory cortical